Real-world data from 24 UK centres for the use of nintedanib for progressive fibrosing interstitial lung disease

被引：0

作者：

Dixon, Giles ^{[1
]}

Hague, Samuel ^{[2
]}

Mulholland, Sarah ^{[2
]}

Khin, Aye Myat Noe ^{[3
]}

Thould, Hannah ^{[3
]}

Connon, Roisin ^{[4
]}

Minnis, Paul ^{[4
]}

Murtagh, Eoin ^{[4
]}

Khan, Fasihul ^{[5
]}

Toor, Sameen ^{[5
]}

Lawrence, Alexandra ^{[6
]}

Naqvi, Marium ^{[6
]}

West, Alex ^{[6
]}

Coker, Robina ^{[7
]}

Ward, Katie ^{[7
]}

Yazbeck, Leda ^{[7
]}

Hart, Simon ^{[8
]}

Garfoot, Theresa ^{[9
]}

Newman, Kate ^{[9
]}

Rivera-Ortega, Pilar ^{[9
]}

Stranks, Lachlan ^{[9
]}

Beirne, Paul ^{[10
]}

Bradley, Jessica ^{[10
]}

Rowan, Catherine ^{[10
]}

Agnew, Sarah ^{[11
]}

Ahmad, Mahin ^{[11
]}

Spencer, Lisa G. ^{[11
]}

Aigbirior, Joshua ^{[12
]}

Fahim, Ahmed ^{[12
]}

Wilson, Andrew M. ^{[13
]}

Butcher, Elizabeth ^{[14
]}

Chong, Sy Giin ^{[14
]}

Saini, Gauri

Zulfikar, Sabrina ^{[15
]}

Chua, Felix ^{[16
]}

George, Peter M. ^{[16
]}

Kokosi, Maria ^{[16
]}

Kouranos, Vasileios ^{[16
]}

Molyneaux, Philip ^{[16
]}

Renzoni, Elisabetta ^{[16
]}

Vitri, Benedetta ^{[16
]}

Wells, Athol U. ^{[16
]}

Nicol, Lisa M. ^{[17
]}

Bianchi, Stephen ^{[18
]}

Kular, Raman ^{[18
]}

Liu, Huajian ^{[19
]}

John, Alexander ^{[19
]}

Barth, Sarah ^{[20
]}

Wickremasinghe, Melissa ^{[20
]}

Forrest, Ian A. ^{[21
]}

机构：

[1] Univ Exeter, Exeter, Devon, England

[2] North Bristol NHS Trust, Bristol, Avon, England

[3] Royal Devon Univ Healthcare NHS Fdn Trust, South West Peninsula ILD Network, Exeter, Devon, England

[4] Northern Hlth & Social Care Trust, Antrim Area Hosp, Antrim, North Ireland

[5] Univ Hosp Leicester NHS Trust, Glenfield Hosp, Leicester, Leics, England

[6] Guys & St Thomas Hosp NHS Fdn Trust, London, England

[7] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England

[8] Hull Univ Teaching Hosp NHS Trust, Kingston Upon Hull, N Humberside, England

[9] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Interstitial Lung Dis Unit, Manchester, Lancs, England

[10] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England

[11] Liverpool Univ Hosp NHS Fdn Trust, Aintree Hosp, Liverpool Interstitial Lung Dis Serv, Liverpool, Merseyside, England

[12] Royal Wolverhampton NHS Trust, New Cross Hosp, Wolverhampton, England

[13] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Norwich, Norfolk, England

[14] Nottingham Univ Hosp NHS Trust, Nottingham, England

[15] Oxford Univ Hosp NHS Fdn Trust, Oxford, England

[16] Royal Brompton & Harefield Hosp, London, England

[17] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland

[18] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

[19] Southern Hlth & Social Care Trust, Portadown, North Ireland

[20] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London, England

[21] Newcastle Tyne Hosp NHS Fdn Trust, Newcastle, England

[22] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England

[23] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England

[24] Univ Hosp Morecambe Bay NHS Fdn Trust, Lancashire & South Cumbria ILD Serv, Lancaster, England

[25] Univ Hosp North Midlands NHS Trust, Stoke On Trent, Staffs, England

[26] Royal United Hosp Bath NHS Fdn Trust, Bath, Avon, England

[27] Univ Exeter, Dept Math & Stat, Fac Environm Sci & Econ, Exeter, Devon, England

[28] Univ Exeter Exeter, Dept Clin & Biomed Sci, Exeter, Devon, England

[29] Royal Devon Univ Healthcare NHS Fdn Trust, Exeter, Devon, England

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA404

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：4

共 50 条

[1] Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK
Dixon, Giles
Hague, Samuel
Mulholland, Sarah
Adamali, Huzaifa
Khin, Aye Myat Noe
Thould, Hannah
Connon, Roisin
Minnis, Paul
Murtagh, Eoin
Khan, Fasihul
Toor, Sameen
Lawrence, Alexandra
Naqvi, Marium
West, Alex
Coker, Robina K.
Ward, Katie
Yazbeck, Leda
Hart, Simon
Garfoot, Theresa
Newman, Kate
Rivera-Ortega, Pilar
Stranks, Lachlan
Beirne, Paul
Bradley, Jessica
Rowan, Catherine
Agnew, Sarah
Ahmad, Mahin
Spencer, Lisa G.
Aigbirior, Joshua
Fahim, Ahmed
Wilson, Andrew M.
Butcher, Elizabeth
Chong, Sy Giin
Saini, Gauri
Zulfikar, Sabrina
Chua, Felix
George, Peter M.
Kokosi, Maria
Kouranos, Vasileios
Molyneaux, Philip
Renzoni, Elisabetta
Vitri, Benedetta
Wells, Athol U.
Nicol, Lisa M.
Bianchi, Stephen
Kular, Raman
Liu, Hua Jian
John, Alexander
Barth, Sarah
Wickremasinghe, Melissa
ERJ OPEN RESEARCH, 2024, 10 (01)
[2] PREDICTORS OF MORTALITY IN PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE PATIENTS TREATED WITH NINTEDANIB: REAL-WORLD DATA FROM A SINGLE ILD SPECIALIST CENTRE
Stranks, L.
Newman, K.
Garfoot, T.
Morris, H.
Zais, K.
Swale, J.
Greaves, M.
Stanel, S.
Ramjug, S.
Avrarn, C.
Blaikley, J.
Leonard, C.
Hayton, C.
Rivera-Ortega, P.
THORAX, 2022, 77 : A92 - A93
[3] NATIONAL UK EXPERIENCE OF THE TREATMENT OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE WITH NINTEDANIB
Dixon, G.
Hague, S.
Thould, H.
Khin, A. M. N.
Mulholland, S.
Gibbons, M.
Barratt, S. L.
THORAX, 2023, 78 (SUPPL_4) : A11 - A12
[4] PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE IN THE REAL WORLD
Balzat, L.
Navaratnam, V
Godfrey, E.
Watters, C.
Reddy, T.
Bancroft, S.
Divithotawela, C.
Godbolt, D.
Pauli, J.
Goddard, J.
Trotter, M.
Hopkins, P.
Chambers, D.
Mackintosh, J.
RESPIROLOGY, 2021, 26 : 170 - 170
[5] REAL-WORLD TOLERABILITY STUDY OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASE COMPARED TO PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
Newman, K.
Gadoot, T.
Stranks, L.
Morris, H.
Zakis, K.
Swale, J.
Greaves, M.
Stanel, S.
Ramjug, S.
Avram, C.
Blaikley, J.
Leonard, C.
Hayton, C.
Rivera-Ortega, P.
THORAX, 2022, 77 : A96 - A96
[6] Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
Niitsu, Takayuki
Fukushima, Kiyoharu
Komukai, Sho
Takata, So
Abe, Yuko
Nii, Takuro
Kuge, Tomoki
Iwakoshi, Shinichi
Shiroyama, Takayuki
Miyake, Kotaro
Tujino, Kazuyuki
Tanizaki, Satoshi
Iwahori, Kota
Hirata, Haruhiko
Miki, Keisuke
Yanagawa, Masahiro
Takeuchi, Noriyuki
Takeda, Yoshito
Kida, Hiroshi
Kumanogoh, Atsushi
RMD OPEN, 2023, 9 (01):
[7] Outcomes in real-life nintedanib treatment of progressive fibrosing interstitial lung disease.
Calzolari, Elisa
Callari, Adriana
Martino, Lavinia
Lanzarone, Nicola
Miceli, Vitale
Vitulo, Patrizio
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[8] Characteristics in patients with Progressive Fibrosing Interstitial Lung Disease (PFILD) treated with Nintedanib: data from a specialist centre
Johnston, Janet
Stranks, Lachlan
Newman, Kate
Garfoot, Theresa
Pearmain, Laurence
Stanel, Stefan
Hayton, Conal
Leonard, Colm
Melanie, Greaves
Rivera-Ortega, Pilar
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[9] From Bench to Bedside: Nintedanib for Progressive Fibrosing Interstitial Lung Diseases
Garlick, Kristopher
Wollin, Lutz
Distler, Joerg
Stowasser, Susanne
Schlenker-Herceg, Rozsa
JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 822 - 822
[10] FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES
Wollin, L.
Distler, J.
Redente, E.
Riches, D.
Stowasser, S.
Schlenker-Herceg, R.
RESPIROLOGY, 2019, 24 : 171 - 171

← 1 2 3 4 5 →